SCHEMBL537785

SCHEMBL537785

CC(C)[Si](C)(C)OS(=O)(=O)C(F)(F)F

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14981496 0.86
SCHEMBL114743 0.79
SCHEMBL631967 0.79
SCHEMBL3468768 0.77
SCHEMBL20337341 0.76
SCHEMBL630962 0.75 CA1 (0.32)
SCHEMBL14777968 0.75 CA1 (0.32)
SCHEMBL28527 0.75 CA1 (0.32)
SCHEMBL10346389 0.74
SCHEMBL38009 0.74

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0143323-B1 PROCESS FOR AN ANTHRACYCLINE DERIVATIVE, AND AN ANTHRACYCLINONE DERIVATIVE USEFUL FOR THE PROCESS SAGAMI CHEMICAL RESEARCH CENTER (JP) 1988-10-26 EP claimed
US-4564674-A Process for an anthracycline derivative, and an anthracyclinone derivative useful for the process SAGAMI CHEMICAL RESEARCH CENTER (JP) 1986-01-14 US claimed
EP-0143323-A2 Process for an anthracycline derivative, and an anthracyclinone derivative useful for the process SAGAMI CHEMICAL RESEARCH CENTER (JP) 1985-06-05 EP claimed
US-11912915-B2 Phosphine precursor for preparing quantum dot and quantum dot prepared therefrom SK CHEMICALS CO., LTD. (KR) 2024-02-27 US disclosed
US-11912915-B2 Phosphine precursor for preparing quantum dot and quantum dot prepared therefrom SK CHEMICALS CO., LTD. (KR) 2024-02-27 US disclosed
US-11912915-B2 Phosphine precursor for preparing quantum dot and quantum dot prepared therefrom SK CHEMICALS CO., LTD. (KR) 2024-02-27 US disclosed
US-11572434-B2 Curable composition, method for producing same, and article using same DAIKIN INDUSTRIES, LTD. (JP) 2023-02-07 US disclosed
US-20210189052-A1 CURABLE COMPOSITION, METHOD FOR PRODUCING SAME, AND ARTICLE USING SAME DAIKIN INDUSTRIES, LTD. (JP) 2021-06-24 US disclosed
US-10781335-B2 Functional film DAIKIN INDUSTRIES, LTD. (JP) 2020-09-22 US disclosed
US-10731048-B2 2020-08-04 US disclosed
US-20200071608-A1 PHOSPHINE PRECURSOR FOR PREPARING QUANTUM DOT AND QUANTUM DOT PREPARED THEREFROM SK CHEMICALS CO., LTD. (KR) 2020-03-05 US disclosed
EP-2415800-A1 HYPERBRANCHED POLYOXYALKYLENE COMPOUND AND METHOD FOR PRODUCING SAME NOF Corporation (JP) 2012-02-08 EP disclosed
US-20100261863-A1 MULTIBRANCHED POLYOXYALKYLENE COMPOUND AND PRODUCING METHOD THEREOF NOF CORPORATION (JP) 2010-10-14 US disclosed
WO-2009038411-A2 BETA-SECRETASE INHIBITING COMPOUNDS HAVING OXO-DIHYDRO-PYRAZOLE MOIETY LG LIFE SCIENCES, LTD. (KR) 2009-03-26 WO disclosed
US-20030181742-A1 Process for the preparation of pregnane derivatives KURARAY CO., LTD. (JP) 2003-09-25 US disclosed
EP-1325928-A1 PROCESS FOR THE PREPARATION OF PREGNANE DERIVATIVES Kuraray Co., Ltd. (JP) 2003-07-09 EP disclosed
US-5705702-A REACTING AN ARYL GRIGNARD REAGENT WITH THIONYL CHLORIDE, THEN WITH TRIORGANOSILYL SULFONATE OR TRIORGANOSILYLHALIDE SHIN-ETSU CHEMICAL CO., LTD. (JP) 1998-01-06 US disclosed
EP-0143323-B1 PROCESS FOR AN ANTHRACYCLINE DERIVATIVE, AND AN ANTHRACYCLINONE DERIVATIVE USEFUL FOR THE PROCESS SAGAMI CHEMICAL RESEARCH CENTER (JP) 1988-10-26 EP disclosed
US-4564674-A Process for an anthracycline derivative, and an anthracyclinone derivative useful for the process SAGAMI CHEMICAL RESEARCH CENTER (JP) 1986-01-14 US disclosed
EP-0143323-A2 Process for an anthracycline derivative, and an anthracyclinone derivative useful for the process SAGAMI CHEMICAL RESEARCH CENTER (JP) 1985-06-05 EP disclosed